TransMedics
TMDX
81.07
+0.79
+0.98%
TransMedics
US · TMDX
#2536 by market cap
Listed 2019
81.07
+0.79
+0.98%
Live - 5344 symbols - heartbeat 22s ago
· 2026-10-08 04:04
Pre-market
80.22
-1.05%
After-hours
81.07
0.00%
Overnight
80.22
-1.05%
- Market cap
- 2.81B
- P/E (TTM)i
- 21.00
- P/Bi
- 5.43
- EPSi
- 4.87
- Div yieldi
- 0.00%
- 52W posi
- 22%
Reader sentiment
Are you bullish or bearish on TMDX?
Anonymous reader poll. Unscientific, not investment advice.
Analyst consensus 7 analysts
Buy
Avg price target
108.60 +34.0%
Price target rangecurrent 81.07
Low95.00
Avg108.60
High122.00
Buy 86%
Hold 14%
Sell 0%
Recent ratings (25)
| Date | Firm | Analyst | Rating | Target |
|---|---|---|---|---|
| 2026-10-05 | Piper Sandler | -- | BUY | 100.00 |
| 2026-10-02 | TD Cowen | -- | BUY | 120.00 |
| 2026-10-02 | William Blair | -- | BUY | -- |
| 2026-09-22 | Needham | -- | BUY | 106.00 |
| 2026-09-11 | CCORF | -- | BUY | 95.00 |
| 2026-09-11 | Piper Sandler | -- | BUY | 100.00 |
| 2026-09-11 | Needham | -- | BUY | 106.00 |
| 2026-09-10 | William Blair | -- | BUY | -- |
| 2026-09-08 | TD Cowen | -- | BUY | 120.00 |
| 2026-09-02 | TD Cowen | -- | BUY | 120.00 |
| 2026-09-02 | Piper Sandler | -- | BUY | 90.00 |
| 2026-08-24 | Oppenheimer | -- | HOLD | -- |
| 2026-08-12 | CCORF | -- | BUY | 95.00 |
| 2026-08-11 | CCORF | -- | BUY | 95.00 |
| 2026-08-05 | TD Cowen | -- | BUY | 120.00 |
| 2026-08-05 | CCORF | -- | BUY | 95.00 |
| 2026-08-05 | Piper Sandler | -- | BUY | 100.00 |
| 2026-08-05 | Baird | -- | BUY | 122.00 |
| 2026-08-04 | William Blair | -- | BUY | -- |
| 2026-08-04 | Piper Sandler | -- | BUY | 120.00 |
| 2026-08-03 | Needham | -- | BUY | 106.00 |
| 2026-08-02 | TD Cowen | -- | BUY | 120.00 |
| 2026-07-22 | Piper Sandler | -- | BUY | 120.00 |
| 2026-07-21 | William Blair | -- | BUY | -- |
| 2026-07-11 | TD Cowen | -- | BUY | 120.00 |
Quant vs Street three independent views, side by side
Momentum strategy signal
Strong Sell
Analyst consensus
Buy
Signals diverge - worth digging into why.
Not investment advice. The factor grade ranks this stock on fundamentals against StockVane's covered universe; the momentum strategy signal is a rules-based backtest, not a recommendation; analyst consensus reflects sell-side coverage. The three use different methods and can reasonably disagree.
Price target trend monthly average, last 3 years
✦ Quant Analyst Revision Trend how this is computed
Mixed
1
■ Upgrades■ Downgrades
- 0 upgrades vs 1 downgrade among tracked analyst rating changes.
- Most recent: Oppenheimer moved from Buy to Hold on 2026-05-06.
Recent rating changes
| Date | Firm | Change | Target |
|---|---|---|---|
| 2026-05-06 | Oppenheimer | BUY → HOLD | 175.00 |
Earnings history price reaction on the day
| Period | Report date | Session | Options expected | Actual move |
|---|---|---|---|---|
| 2026/Q2 | 2026-08-04 | After close | ±15.60% | -5.28% (in line) |
| 2026/Q1 | 2026-05-05 | After close | ±12.87% | -23.19% (beat) |
| 2025/Q4 | 2026-02-24 | After close | ±15.97% | -4.30% (in line) |
| 2025/Q3 | 2025-10-29 | After close | ±17.52% | +1.09% (in line) |
| 2025/Q2 | 2025-07-30 | After close | ±19.01% | +10.46% (in line) |
| 2025/Q1 | 2025-05-08 | After close | ±19.30% | +19.64% (beat) |
| 2024/Q4 | 2025-02-27 | After close | ±27.26% | +5.82% (in line) |
| 2024/Q3 | 2024-10-28 | After close | ±24.84% | -29.90% (beat) |
| 2024/Q1 | 2024-04-30 | After close | ±18.67% | +24.93% (beat) |
| 2023/Q4 | 2024-02-26 | After close | ±27.53% | +14.11% (in line) |
| 2023/Q3 | 2023-11-06 | After close | ±20.79% | +51.18% (beat) |
| 2023/Q2 | 2023-08-03 | After close | ±16.84% | -8.31% (in line) |
"Options expected" is the pre-earnings options market's implied move (a straddle-style estimate), shown next to what actually happened.
Quote time 2026-10-08 04:04:22 · For reference only, not investment advice and not tailored to your situation.